Stock Agreements
Biotechnology
Biotechnology (3,694) | Stock Agreements (62,606)
- 4D Molecular Therapeutics Inc (2 contracts)
- 89bio, Inc. (2)
- AbbVie Inc. (26)
- ABEONA THERAPEUTICS INC. (4)
- ACADIA PHARMACEUTICALS INC (4)
- ACCELERON PHARMA INC (4)
- Accustem Sciences Inc. (2)
- Achaogen, Inc. (6)
- ACHIEVE LIFE SCIENCES, INC. (8)
- Acorda Therapeutics (13)
- Actinium Pharmaceuticals, Inc. (16)
- Acumen Pharmaceuticals, Inc. (2)
- Acurx Pharmaceuticals, LLC (1)
- Adagio Therapeutics, Inc. (3)
- Adamas Pharmaceuticals Inc (6)
- Adhera Therapeutics, Inc. (12)
- ADiTx Therapeutics, Inc. (2)
- ADMA BIOLOGICS, INC. (6)
- ADURO BIOTECH, INC. (7)
- Advaxis, Inc. (9)
- Adverum Biotechnologies, Inc. (6)
- Aeglea BioTherapeutics, Inc. (3)
- Aerovate Therapeutics, Inc. (2)
- AGENUS INC (15)
- AGIOS PHARMACEUTICALS INC (4)
- AILERON THERAPEUTICS INC (2)
- Aimmune Therapeutics, Inc. (7)
- AKCEA THERAPEUTICS, INC. (3)
- Akebia Therapeutics, Inc. (5)
- Akero Therapeutics, Inc. (4)
- Akouos, Inc. (12)
- ALBIREO PHARMA, INC. (10)
- Aldeyra Therapeutics, Inc. (3)
- Alector, Inc. (3)
- Alexion Pharmaceuticals (8)
- Aligos Therapeutics, Inc. (2)
- Allakos Inc. (4)
- Allarity Therapeutics, Inc. (3)
- Allena Pharmaceuticals, Inc. (2)
- Alliqua BioMedical, Inc. (31)
- Allogene Therapeutics, Inc. (4)
- Allovir, Inc. (4)
- ALNYLAM PHARMACEUTICALS, INC. (23)
- Alpha Healthcare Acquisition Corp. (10)
- ALPINE IMMUNE SCIENCES, INC. (12)
- Altimmune, Inc. (7)
- ALX ONCOLOGY HOLDINGS INC (2)
- AMARILLO BIOSCIENCES INC (10)
- AMARIN CORP PLC (8)
- Amgen Inc. (8)
- AMICUS THERAPEUTICS, INC. (10)
- AmpliPhi Biosciences Corp (4)
- Amplitude Healthcare Acquisition Corp (5)
- ANAPTYSBIO INC (1)
- ANAVEX LIFE SCIENCES CORP. (3)
- Anika Therapeutics (3)
- Anixa Biosciences Inc (6)
- Annexon, Inc. (6)
- Annovis Bio, Inc. (1)
- Apellis Pharmaceuticals, Inc. (3)
- APPLIED GENETIC TECHNOLOGIES CORP (2)
- Applied Molecular Transport Inc. (3)
- Applied Therapeutics Inc. (2)
- Aprea Therapeutics, Inc. (4)
- Aptevo Therapeutics Inc. (2)
- Aptinyx Inc. (1)
- AQUINOX PHARMACEUTICALS, INC (2)
- Aravive, Inc. (5)
- Arbutus Biopharma Corp (2)
- ARCA biopharma, Inc. (15)
- Arcellx, Inc. (5)
- Arcturus Therapeutics Holdings Inc. (3)
- Arcus Biosciences, Inc. (7)
- Arcutis Biotherapeutics, Inc. (3)
- ARDELYX, INC. (1)
- ARENA PHARMACEUTICALS INC (15)
- Aridis Pharmaceuticals, Inc. (1)
- ARROWHEAD PHARMACEUTICALS, INC. (20)
- Arsanis, Inc. (4)
- Artiva Biotherapeutics, Inc. (2)
- ARYA Sciences Acquisition Corp II (2)
- ASSEMBLY BIOSCIENCES, INC. (8)
- Atara Biotherapeutics, Inc. (5)
- Athenex, Inc. (4)
- ATHERSYS, INC (10)
- ATOSSA GENETICS INC (10)
- Atreca, Inc. (5)
- aTYR PHARMA INC (9)
- Aura Biosciences, Inc. (3)
- Aurinia Pharmaceuticals Inc. (1)
- AVEO PHARMACEUTICALS INC (13)
- Avid Bioservices, Inc. (6)
- Avidity Biosciences, Inc. (2)
- Avita Therapeutics, Inc. (3)
- AVROBIO, Inc. (3)
- Axcella Health Inc. (2)
- Axovant Sciences Ltd. (1)
- Ayala Pharmaceuticals, Inc. (1)
- AZIYO BIOLOGICS, INC. (6)
- AzurRx BioPharma, Inc. (3)
- BCTG Acquisition Corp. (8)
- Beam Therapeutics Inc. (7)
- BELLICUM PHARMACEUTICALS, INC (2)
- Big Cypress Acquisition Corp. (3)
- BIO-PATH HOLDINGS INC (1)
- bioAffinity Technologies, Inc. (1)
- BioAtla, Inc. (6)
- BioCardia, Inc. (4)
- BIOCEPT INC (10)
- BIOCRYST PHARMACEUTICALS INC (9)
- Biogen Inc. (22)
- Biohaven Pharmaceutical Holding Co Ltd. (2)
- BioLife4D Corp (3)
- BIOMARIN PHARMACEUTICAL INC (11)
- Biomea Fusion, Inc. (2)
- BioNexus Gene Lab Coporation (1)
- BioRestorative Therapies, Inc. (23)
- BIOSPECIFICS TECHNOLOGIES CORP (7)
- Biostage, Inc. (3)
- BIOTIME INC (28)
- BIOVIE INC. (2)
- BioXcel Therapeutics, Inc. (2)
- BIOXYTRAN, INC (4)
- Black Diamond Therapeutics, Inc. (2)
- Blue Water Vaccines Inc. (1)
- bluebird bio, Inc. (4)
- Blueprint Medicines Corp (3)
- Bolt Biotherapeutics, Inc. (2)
- Bone Biologics Corp (7)
- BRAINSTORM CELL THERAPEUTICS INC. (4)
- BriaCell Therapeutics Corp. (1)
- BridgeBio Pharma, Inc. (5)
- BullFrog AI Holdings, Inc. (1)
- BURZYNSKI RESEARCH INSTITUTE INC (1)
- C4 Therapeutics, Inc. (4)
- Cabaletta Bio, Inc. (4)
- CALADRIUS BIOSCIENCES, INC. (13)
- Calithera Biosciences, Inc. (4)
- Calyxt, Inc. (2)
- CANCER GENETICS, INC (13)
- Candel Therapeutics, Inc. (3)
- CAPRICOR THERAPEUTICS, INC. (14)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (5)
- Capstone Therapeutics Corp. (5)
- CareDx, Inc. (2)
- Caribou Biosciences, Inc. (5)
- CASI Pharmaceuticals, Inc. (7)
- CASTLE BIOSCIENCES INC (7)
- CATABASIS PHARMACEUTICALS INC (5)
- CATALYST BIOSCIENCES, INC. (12)
- CATALYST PHARMACEUTICALS, INC. (12)
- CEL SCI CORP (2)
- Celcuity Inc. (2)
- Cell Source, Inc. (3)
- Celldex Therapeutics, Inc. (14)
- Cellectar Biosciences, Inc. (17)
- Cellular Biomedicine Group, Inc. (9)
- Celsion CORP (8)
- Centessa Pharmaceuticals Ltd (1)
- Century Therapeutics, Inc. (12)
- CEREBAIN BIOTECH CORP. (5)
- Chanticleer Holdings, Inc. (9)
- Chardan Healthcare Acquisition 2 Corp. (4)
- Chardan Healthcare Acquisition Corp. (3)
- Checkmate Pharmaceuticals, Inc. (4)
- Chelsea Worldwide Inc. (1)
- ChemoCentryx, Inc. (9)
- CHIMERIX INC (4)
- Cibus Global, Ltd. (5)
- Cidara Therapeutics, Inc. (5)
- CLEVELAND BIOLABS INC (4)
- Clovis Oncology, Inc. (4)
- CM Life Sciences III Inc. (6)
- Codiak BioSciences, Inc. (6)
- CohBar, Inc. (1)
- Coherus BioSciences, Inc. (4)
- Comera Life Sciences Holdings, Inc. (1)
- Conatus Pharmaceuticals Inc. (10)
- CONCERT PHARMACEUTICALS, INC. (4)
- Consonance-HFW Acquisition Corp. (3)
- Constellation Alpha Capital Corp. (7)
- CONSTELLATION PHARMACEUTICALS INC (2)
- CONTRAFECT Corp (6)
- Corbus Pharmaceuticals Holdings, Inc. (4)
- Cortexyme, Inc. (5)
- Crinetics Pharmaceuticals, Inc. (2)
- CRISPR Therapeutics AG (2)
- CTI BIOPHARMA CORP (6)
- Cue Biopharma, Inc. (2)
- Cullinan Oncology, LLC (2)
- Curative Biotechnology Inc (10)
- CURIS INC (13)
- Cyclacel Pharmaceuticals, Inc. (9)
- Cyclerion Therapeutics, Inc. (1)
- CytoDyn Inc. (16)
- Cytokinetics, Incorporated (14)
- CytomX Therapeutics, Inc. (2)
- CYTORI THERAPEUTICS, INC. (21)
- CYTRX CORP (9)
- Day One Biopharmaceuticals Holding Co LLC (3)
- DBV Technologies S.A. (3)
- Decibel Therapeutics, Inc. (4)
- DECIPHER BIOSCIENCES, INC. (2)
- Deciphera Pharmaceuticals, Inc. (4)
- DelMar Pharmaceuticals, Inc. (4)
- Denali Therapeutics Inc. (11)
- Dermira, Inc. (3)
- Design Therapeutics, Inc. (3)
- DiaMedica Therapeutics Inc. (3)
- Dicerna Pharmaceuticals Inc (11)
- Diffusion Pharmaceuticals Inc. (10)
- Digital Development Partners, Inc. (1)
- DYADIC INTERNATIONAL INC (2)
- Dynamics Special Purpose Corp. (5)
- DYNAVAX TECHNOLOGIES CORP (9)
- Dyne Therapeutics, Inc. (3)
- Eagle Pharmaceuticals, Inc. (5)
- Edge Therapeutics, Inc. (4)
- Editas Medicine, Inc. (4)
- Eidos Therapeutics, Inc. (2)
- Eiger BioPharmaceuticals, Inc. (6)
- Elevation Oncology, Inc. (2)
- Eliem Therapeutics, Inc. (2)
- Emerald Bioscience, Inc. (5)
- Emergent BioSolutions Inc. (21)
- Enanta Pharmaceuticals, Inc. (4)
- ENDONOVO THERAPEUTICS, INC. (3)
- Entasis Therapeutics Holdings Inc. (4)
- Entrada Therapeutics, Inc. (3)
- Environmental Impact Acquisition Corp (6)
- ENZON PHARMACEUTICALS, INC. (1)
- Epizyme, Inc. (6)
- Equillium, Inc. (4)
- Erasca, Inc. (2)
- Esperion Therapeutics, Inc. (6)
- ESSA Pharma Inc. (3)
- Evelo Biosciences, Inc. (5)
- EVOLUTIONARY GENOMICS, INC. (2)
- EXACT SCIENCES CORP (9)
- Exelixis (15)
- EXICURE, INC. (2)
- FATE THERAPEUTICS INC (5)
- FENNEC PHARMACEUTICALS INC. (3)
- Fibrocell Science, Inc. (7)
- FIBROGEN INC (4)
- Finch Therapeutics Group, Inc. (2)
- FIVE PRIME THERAPEUTICS INC (4)
- Flex Pharma, Inc. (5)
- Flexion Therapeutics Inc (5)
- FLUOROPHARMA MEDICAL, INC. (3)
- Foghorn Therapeutics Inc. (3)
- Forma Therapeutics Holdings, Inc., (2)
- Fortress Biotech, Inc. (10)
- Forty Seven, Inc. (2)
- Frequency Therapeutics, Inc. (3)
- FS Development Corp. (9)
- FS Development Corp. II (5)
- G1 Therapeutics, Inc. (1)
- Gain Therapeutics, Inc. (3)
- GALECTIN THERAPEUTICS INC (11)
- Galecto Inc. (3)
- Galera Therapeutics, Inc. (2)
- Gemphire Therapeutics Inc. (5)
- Gene Biotherapeutics, Inc. (3)
- GENELUX CORP (3)
- Generation Bio Co. (3)
- GENEREX BIOTECHNOLOGY CORP (35)
- GENOCEA BIOSCIENCES, INC. (4)
- Genprex, Inc. (5)
- GeoVax Labs, Inc. (22)
- GERON CORP (19)
- Gilead Sciences (27)
- Global Blood Therapeutics, Inc. (3)
- GLYCOMIMETICS INC (4)
- Gossamer Bio, Inc. (5)
- Grail, Inc. (1)
- Graphite Bio, Inc. (3)
- Greenwich LifeSciences, Inc. (1)
- Gritstone Oncology, Inc. (5)
- GT Biopharma, Inc. (7)
- GTX INC (16)
- GX Acquisition Corp. (3)
- HALOZYME THERAPEUTICS INC (22)
- HARBOR DIVERSIFIED, INC. (7)
- Harpoon Therapeutics, Inc. (4)
- HCW Biologics Inc. (2)
- Health Sciences Acquisitions Corp (6)
- HEAT BIOLOGICS, INC. (15)
- HedgePath Pharmaceuticals, Inc. (2)
- HEMISPHERX BIOPHARMA INC (12)
- HERON THERAPEUTICS, INC. (2)
- HilleVax, Inc. (2)
- Hillstream BioPharma Inc. (1)
- HISTOGENICS CORP (13)
- Homology Medicines, Inc. (4)
- HOOKIPA Pharma Inc. (4)
- HST Global, Inc. (1)
- HUMANIGEN, INC (4)
- iBio, Inc. (6)
- Icosavax, Inc. (2)
- IDEAYA Biosciences, Inc. (5)
- IDERA PHARMACEUTICALS, INC. (20)
- IGM Biosciences, Inc. (7)
- Imago BioSciences, Inc. (2)
- Immix Biopharma, Inc. (1)
- IMMUCELL CORP (2)
- IMMUNE PHARMACEUTICALS INC (9)
- Immune Therapeutics, Inc. (3)
- Immuneering Corp (2)
- ImmunoCellular Therapeutics, Ltd. (6)
- IMMUNOGEN INC (13)
- Immunome Inc. (4)
- IMMUNOMEDICS INC (17)
- IMPEL NEUROPHARMA INC (2)
- IN8BIO, INC. (2)
- Incyte (20)
- INFINITY PHARMACEUTICALS, INC. (17)
- Inhibikase Therapeutics, Inc. (2)
- Inhibrx, Inc. (1)
- InMed Pharmaceuticals Inc. (2)
- Inmune Bio, Inc. (3)
- Innovation Pharmaceuticals Inc. (10)
- INOVIO PHARMACEUTICALS, INC. (9)
- Inozyme Pharma, Inc. (3)
- INSMED Inc (5)
- Inspyr Therapeutics, Inc. (9)
- Instil Bio, Inc. (1)
- Intellia Therapeutics, Inc. (4)
- INTERCEPT PHARMACEUTICALS, INC. (16)
- International Stem Cell CORP (16)
- INTREXON CORP (10)
- Intrinsic Medicine, Inc. (3)
- Invitae Corp (5)
- IO Biotech, Inc. (1)
- IONIS PHARMACEUTICALS INC (8)
- IOVANCE BIOTHERAPEUTICS, INC. (12)
- IRONWOOD PHARMACEUTICALS INC (5)
- Isoray, Inc. (20)
- iTeos Therapeutics, Inc. (4)
- Janux Therapeutics, Inc. (3)
- Jounce Therapeutics, Inc. (5)
- Kadmon Holdings, Inc. (5)
- KalVista Pharmaceuticals, Inc. (5)
- Karuna Therapeutics, Inc. (3)
- Karyopharm Therapeutics Inc. (9)
- KBL MERGER CORP. IV (5)
- Keros Therapeutics, Inc. (3)
- Kezar Life Sciences, Inc. (3)
- Kindred Biosciences, Inc. (2)
- Kinnate Biopharma Inc. (2)
- Kiromic Biopharma, Inc. (3)
- KIWA BIO-TECH PRODUCTS GROUP CORP (5)
- Kodiak Sciences Inc. (4)
- Kronos Bio, Inc. (5)
- Krystal Biotech, Inc. (4)
- Kura Oncology, Inc. (2)
- Kymera Therapeutics, Inc. (5)
- LA JOLLA PHARMACEUTICAL CO (7)
- Lantern Pharma Inc. (2)
- LEAP THERAPEUTICS, INC. (1)
- Leisure Acquisition Corp. (6)
- LEXICON PHARMACEUTICALS, INC. (18)
- LifeSci Acquisition Corp. (6)
- Ligand Pharmaceuticals Incorporated (21)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
- Locust Walk Acquisition Corp. (5)
- LogicBio Therapeutics, Inc. (2)
- LONGEVERON LLC (2)
- Lyell Immunopharma, Inc. (3)
- MACROGENICS INC (6)
- MADRIGAL PHARMACEUTICALS, INC. (15)
- Magenta Therapeutics, Inc. (3)
- MAIA Biotechnology, Inc. (2)
- MANHATTAN SCIENTIFICS INC (1)
- MANNKIND CORP (12)
- MARIZYME INC (18)
- Marker Therapeutics, Inc. (18)
- MATEON THERAPEUTICS INC (9)
- Matinas BioPharma Holdings, Inc. (3)
- MAXCYTE, INC. (2)
- MEDICINOVA INC (9)
- Medovex Corp. (1)
- MEI Pharma, Inc. (12)
- MERRIMACK PHARMACEUTICALS INC (3)
- Mersana Therapeutics, Inc. (4)
- Metacrine, Inc. (4)
- Millendo Therapeutics, Inc. (14)
- MiMedx Group, Inc. (21)
- Minerva Neurosciences, Inc. (8)
- MiNK Therapeutics, Inc. (3)
- MIRAGEN THERAPEUTICS, INC. (4)
- Mirati Therapeutics, Inc. (5)
- Mirum Pharmaceuticals, Inc. (8)
- Moderna, Inc. (10)
- Molecular Templates, Inc. (9)
- Moleculin Biotech, Inc. (2)
- Momenta Pharmaceuticals, Inc. (6)
- Monopar Therapeutics (5)
- Monte Rosa Therapeutics, Inc. (4)
- Morphic Holding, Inc. (3)
- MUSTANG BIO, INC. (2)
- Myovant Sciences Ltd. (3)
- Myriad Genetics, Inc. (12)
- NANOVIRICIDES, INC. (18)
- NantKwest, Inc. (1)
- Natera, Inc. (5)
- NAVIDEA BIOPHARMACEUTICALS, INC. (25)
- NEUROBIOLOGICAL TECHNOLOGIES INC (1)
- NEUROCRINE BIOSCIENCES INC (3)
- NEUROTROPE BIOSCIENCE, INC. (2)
- Neurotrope, Inc. (2)
- NEWLINK GENETICS CORP (18)
- NexImmune, Inc. (1)
- NextCure, Inc. (1)
- Nkarta, Inc. (4)
- NORTHWEST BIOTHERAPEUTICS INC (14)
- NOVAVAX INC (10)
- Novus Therapeutics, Inc. (5)
- NTN BUZZTIME INC (3)
- Nuo Therapeutics, Inc. (4)
- Nurix Therapeutics, Inc. (2)
- Nuvalent, Inc. (4)
- Nuvectis Pharma, Inc. (2)
- Ohr Pharmaceutical Inc (11)
- Olema Pharmaceuticals, Inc. (7)
- Olivia Ventures, Inc. (1)
- Omega Therapeutics, Inc. (3)
- OncBioMune Pharmaceuticals, Inc (8)
- OncoCyte Corp (3)
- Oncorus, Inc. (3)
- ONCOSEC MEDICAL Inc (9)
- OPGEN INC (11)
- Ophthotech Corp. (6)
- Opko Health, Inc. (8)
- ORAGENICS INC (22)
- Organicell Regenerative Medicine, Inc. (6)
- Organogenesis Holdings Inc. (2)
- ORGANOVO HOLDINGS, INC. (7)
- Orgenesis Inc. (2)
- Oric Pharmaceuticals, Inc. (3)
- Outlook Therapeutics, Inc. (3)
- Ovid Therapeutics Inc. (3)
- Oyster Point Pharma, Inc. (4)
- PALATIN TECHNOLOGIES INC (1)
- Pasithea Therapeutics Corp. (2)
- Passage BIO, Inc. (2)
- PDL BIOPHARMA, INC. (18)
- PepGen Inc. (3)
- Petra Acquisition Inc. (5)
- Pfenex Inc. (3)
- PharmaCyte Biotech, Inc. (9)
- PhaseBio Pharmaceuticals Inc (3)
- Phio Pharmaceuticals Corp. (6)
- PIERIS PHARMACEUTICALS, INC. (4)
- PLURISTEM THERAPEUTICS INC (12)
- PMV Pharmaceuticals, Inc. (3)
- POLARITYTE, INC. (19)
- PORTOLA PHARMACEUTICALS INC (6)
- Poseida Therapeutics, Inc. (4)
- Praxis Precision Medicines, Inc. (2)
- PRECISION BIOSCIENCES INC (4)
- Prelude Therapeutics Inc (4)
- PREMIER BIOMEDICAL INC (2)
- Prevail Therapeutics Inc. (2)
- Principia Biopharma Inc. (3)
- Progenics Pharmaceuticals, Inc. (5)
- PROGENITY, INC. (11)
- Prometheus Biosciences, Inc. (2)
- ProMIS Neurosciences Inc. (1)
- Propanc Biopharma, Inc. (3)
- Protagenic Therapeutics, Inc. (7)
- Protagonist Therapeutics, Inc (1)
- Protalix BioTherapeutics, Inc. (4)
- PROTEON THERAPEUTICS INC (6)
- PROTEOSTASIS THERAPEUTICS, INC. (2)
- PTC THERAPEUTICS, INC. (9)
- Pyxis Oncology, Inc. (2)
- Q BioMed Inc. (1)
- Qrons Inc. (1)
- Radius Health, Inc. (12)
- Rallybio Corp (2)
- RAPT Therapeutics, Inc. (4)
- Rasna Therapeutics Inc. (1)
- RECURSION PHARMACEUTICALS, INC. (3)
- Regeneron Pharmaceuticals (10)
- REGENERX BIOPHARMACEUTICALS INC (2)
- REGENXBIO Inc. (2)
- Regulus Therapeutics Inc. (9)
- Relay Therapeutics, Inc. (4)
- Reneo Pharmaceuticals, Inc. (4)
- RenovaCare, Inc. (4)
- RenovoRx, Inc. (1)
- Replimune Group, Inc. (5)
- Retrophin, Inc. (8)
- Revolution Medicines, Inc. (4)
- REXAHN PHARMACEUTICALS, INC. (9)
- Rezolute, Inc. (21)
- RHYTHM PHARMACEUTICALS, INC. (5)
- Rich Pharmaceuticals, Inc. (4)
- RIGEL PHARMACEUTICALS INC (14)
- RITTER PHARMACEUTICALS INC (21)
- ROCKET PHARMACEUTICALS, INC. (10)
- Rubius Therapeutics, Inc. (1)
- Sage Therapeutics, Inc. (4)
- Sana Biotechnology, Inc. (5)
- SANGAMO THERAPEUTICS, INC (16)
- Sarepta Therapeutics, Inc. (16)
- Savara Inc (12)
- Scholar Rock Holding Corp (1)
- SEATTLE GENETICS INC (13)
- SELECTA BIOSCIENCES INC (4)
- SELLAS Life Sciences Group, Inc. (7)
- Sensei Biotherapeutics, Inc. (2)
- SERA PROGNOSTICS, INC. (5)
- Seres Therapeutics, Inc. (5)
- Sesen Bio, Inc. (9)
- Shattuck Labs, Inc. (2)
- Shuttle Pharmaceuticals Holdings, Inc. (1)
- Sierra Oncology, Inc. (3)
- Sigilon Therapeutics, Inc. (6)
- Silverback Therapeutics, Inc. (3)
- Social Capital Suvretta Holdings Corp. III (4)
- SOLENO THERAPEUTICS INC (9)
- Solid Biosciences Inc. (4)
- SOLIGENIX, INC. (4)
- SOPHIRIS BIO INC. (3)
- Sorrento Therapeutics, Inc. (24)
- Spectrum Pharmaceuticals, Inc. (6)
- Spero Therapeutics, Inc. (2)
- SPHERIX INC (8)
- Spinning Eagle Acquisition Corp. (5)
- Spring Bank Pharmaceuticals, Inc. (4)
- SpringWorks Therapeutics, Inc. (3)
- SPRUCE BIOSCIENCES, INC. (6)
- SQZ Biotechnologies Co (2)
- Stellar Biotechnologies, Inc. (1)
- Stoke Therapeutics, Inc. (4)
- Sun BioPharma, Inc. (2)
- SUNESIS PHARMACEUTICALS INC (14)
- Surface Oncology, Inc. (4)
- SUTRO BIOPHARMA, INC. (4)
- Syndax Pharmaceuticals Inc (20)
- SYNLOGIC, INC. (5)
- Synthetic Biologics, Inc. (16)
- Syros Pharmaceuticals, Inc. (3)
- T2 Biosystems, Inc. (6)
- Talaris Therapeutics, Inc. (2)
- Taysha Gene Therapies, Inc. (2)
- TCR2 THERAPEUTICS INC. (3)
- TENAX THERAPEUTICS, INC. (28)
- Tenaya Therapeutics, Inc. (2)
- TG THERAPEUTICS, INC. (10)
- Therapeutics Acquisition Corp. (7)
- Tocagen Inc (5)
- Tonix Pharmaceuticals Holding Corp. (6)
- Tracon Pharmaceuticals, Inc. (2)
- Transcode Therapeutics, Inc. (4)
- Translate Bio, Inc. (2)
- TREVENA INC (8)
- Trovagene, Inc. (4)
- TScan Therapeutics, Inc. (3)
- Turning Point Therapeutics, Inc. (3)
- Twist Bioscience Corp (5)
- TYME TECHNOLOGIES, INC. (6)
- Tyra Biosciences, Inc. (2)
- U.S. Stem Cell, Inc. (8)
- Ultragenyx Pharmaceutical Inc. (11)
- Unicycive Therapeutics, Inc. (3)
- United Therapeutics Corp (3)
- Unity Biotechnology, Inc. (5)
- Unum Therapeutics Inc. (4)
- UroGen Pharma Ltd. (2)
- USA EQUITIES CORP. (1)
- VACCINEX, INC. (10)
- Vanda Pharmaceuticals Inc. (2)
- Vaxart, Inc. (6)
- Vaxcyte, Inc. (4)
- Vaxxinity, Inc. (5)
- VBI Vaccines Inc (1)
- Vera Therapeutics, Inc. (3)
- VERACYTE, INC. (6)
- Verastem, Inc. (9)
- Vericel Corp (10)
- Vertex Pharmaceuticals Inc (38)
- Verve Therapeutics, Inc. (2)
- VICAL INC (8)
- Vicapsys Life Sciences, Inc. (1)
- Viela Bio, Inc. (1)
- Vigil Neuroscience, Inc. (2)
- Viking Therapeutics, Inc. (14)
- Vir Biotechnology, Inc. (9)
- Virios Therapeutics, LLC (2)
- VistaGen Therapeutics, Inc. (3)
- VITAL THERAPIES INC (1)
- VITRO DIAGNOSTICS INC (13)
- Vor Biopharma Inc. (2)
- Voyager Therapeutics, Inc. (7)
- vTv Therapeutics Inc. (9)
- Werewolf Therapeutics, Inc. (2)
- WINDTREE THERAPEUTICS INC (21)
- XBiotech Inc. (1)
- Xencor Inc (5)
- Xenetic Biosciences, Inc. (5)
- Xenon Pharmaceuticals Inc. (2)
- Xilio Therapeutics, Inc. (2)
- XOMA Corp (12)
- YIELD10 BIOSCIENCE, INC. (12)
- ZAFGEN, INC. (10)
- Zai Lab Ltd (2)
- Zentalis Pharmaceuticals, LLC (4)
- ZIOPHARM ONCOLOGY INC (4)
- Zymeworks Inc. (3)
- Stock Purchase Agreement, dated (C4 Therapeutics, Inc., Filed With SEC on May 30, 2023)
- Stock Purchase Agreement dated as of May 22, 2023 between Navidea Biopharmaceuticals, Inc. and Irwin Bain (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on May 25, 2023)
- Stock Purchase Agreement dated as of May 22, 2023 between Navidea Biopharmaceuticals, Inc. and Donald E. Garlikov (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on May 25, 2023)
- Stock Option Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant (Replimune Group, Inc., Filed With SEC on May 18, 2023)
- Restricted Stock Unit Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant (Replimune Group, Inc., Filed With SEC on May 18, 2023)
- Form of Common Stock Warrants (Flex Pharma, Inc., Filed With SEC on May 16, 2023)
- Amendment No. 1 to Common Stock Purchase Warrant between 180 Life Sciences Corp. and the warrant holder, dated April 5, 2023 (KBL MERGER CORP. IV, Filed With SEC on May 15, 2023)
- Contingent Value Rights Agreement, dated as of December 26, 2022, between Catalyst and American Stock Transfer & Trust Company, LLC (CATALYST BIOSCIENCES, INC., Filed With SEC on May 15, 2023)
- Stock Purchase Agreement, by and between the Company and the Investors (as defined therein), dated as of May 12, 2023 (VACCINEX, INC., Filed With SEC on May 15, 2023)
- Stock Purchase Agreement dated May 12, 2023 (BriaCell Therapeutics Corp., Filed With SEC on May 15, 2023)
- 2013 Employee Stock Purchase Plan, as amended (Mirati Therapeutics, Inc., Filed With SEC on May 12, 2023)
- Clene Inc. Amended 2020 Stock Plan (Chelsea Worldwide Inc., Filed With SEC on May 11, 2023)
- The Registrant's 2010 Employee Stock Purchase Plan (as amended and restated March 22, 2023) (EXACT SCIENCES CORP, Filed With SEC on May 9, 2023)
- Form of Stock Appreciation Rights Award Agreement for officers (Akebia Therapeutics, Inc., Filed With SEC on May 8, 2023)
- Director Compensation and Stock Ownership Policy, as amended and restated effective April 19, 2023 (Ligand Pharmaceuticals Incorporated, Filed With SEC on May 8, 2023)
- GILEAD SCIENCES, INC. INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN (as Amended and Restated January 25, 2023) Termination Date: January 25, 2033 (Gilead Sciences, Filed With SEC on May 5, 2023)
- GILEAD SCIENCES, INC. EMPLOYEE STOCK PURCHASE PLAN (as Amended and Restated January 25, 2023) Termination Date: January 25, 2033 (Gilead Sciences, Filed With SEC on May 5, 2023)
- Form of Insmed Incorporated Non-Qualified Stock Option Inducement Award Agreement (INSMED Inc, Filed With SEC on May 4, 2023)
- Form of Insmed Incorporated Non-Qualified Stock Option Inducement Award Agreement for non-U.S. employees (INSMED Inc, Filed With SEC on May 4, 2023)
- Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors Stock Option Plan, as amended on March 14, 2023 (IONIS PHARMACEUTICALS INC, Filed With SEC on May 3, 2023)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Restricted Stock Units granted under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002... (IONIS PHARMACEUTICALS INC, Filed With SEC on May 3, 2023)
- Common Stock Purchase Agreement dated as of April 26, 2023 between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- Common Stock Purchase Agreement, dated April 13, 2023, by and between TransCode Therapeutics,Inc. and White Lion Capital LLC (Transcode Therapeutics, Inc., Filed With SEC on April 14, 2023)
- Inducement Stock Option Grant Notice and Aravive, Inc. Inducement Stock Option Agreement, dated April 10, 2023, by and between Aravive, Inc. and Maria Carolina Petrini (Aravive, Inc., Filed With SEC on April 11, 2023)
- Form of Common Stock Certificate (AMARILLO BIOSCIENCES INC, Filed With SEC on April 3, 2023)
- Stock Purchase Agreement by and between the Company and the Investors (as defined therein), dated as of March 30, 2023 (VACCINEX, INC., Filed With SEC on April 3, 2023)
- Description of Common Stock (HEMISPHERX BIOPHARMA INC, Filed With SEC on March 31, 2023)
- Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan (VICAL INC, Filed With SEC on March 30, 2023)
- Form of Stock Option Grant Notice issued under the Ocuphire Pharma, Inc. 2021 Inducement Plan (REXAHN PHARMACEUTICALS, INC., Filed With SEC on March 30, 2023)
- Form of Stock Option Grant Notice and Option Agreement for Atreca, Inc. 2023 Inducement Plan (Atreca, Inc., Filed With SEC on March 29, 2023)
- Non-Qualified Stock Option Award Agreement, dated as of February 17, 2023, between BioRestorative Therapies, Inc. and David Rosa (BioRestorative Therapies, Inc., Filed With SEC on March 27, 2023)
- Non-Qualified Stock Option Award Agreement, dated as of February 17, 2023, between BioRestorative Therapies, Inc. and Patrick F. Williams (BioRestorative Therapies, Inc., Filed With SEC on March 27, 2023)
- Non-Qualified Stock Option Award Agreement, dated as of February 17, 2023, between BioRestorative Therapies, Inc. and Nickolay Kukekov (BioRestorative Therapies, Inc., Filed With SEC on March 27, 2023)
- Form of Restricted Stock Unit Award Agreement (approved October 2020) (AZIYO BIOLOGICS, INC., Filed With SEC on March 23, 2023)
- Description of Capital Stock (ALPINE IMMUNE SCIENCES, INC., Filed With SEC on March 23, 2023)
- Description of Common Stock (Regulus Therapeutics Inc., Filed With SEC on March 23, 2023)
- Description of Capital Stock (AzurRx BioPharma, Inc., Filed With SEC on March 20, 2023)
- Description of the Companys Common Stock, par value $0.001 per share (CAPRICOR THERAPEUTICS, INC., Filed With SEC on March 17, 2023)
- Description of Registrants Common Stock (incorporated by reference to Exhibit 4.4 to the registrants Annual Report on Form 10-K (File No. 001-39592), filed with the SEC on... (Kronos Bio, Inc., Filed With SEC on March 15, 2023)
- Form of Stock Option Award Agreement (Virios Therapeutics, LLC, Filed With SEC on March 14, 2023)